Panax notoginseng extract, known as artemisinin in Panax notoginseng
-
Last Update: 2016-04-11
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Cardiovascular and cerebrovascular diseases are caused by "junk blood" characterized by hyperlipidemia, which leads to "Scaling" and "blockage" of blood vessels It is a necessary way to prevent and treat cardiovascular and cerebrovascular diseases by dissolving thrombus in blood vessels, removing rubbish in blood and unblocking blood circulation, which is also unanimously recognized by cardiovascular experts in traditional Chinese and Western medicine The position of Sanqi in the heart of experts of traditional Chinese and Western Medicine Professor Li Lianda, academician of Chinese Academy of engineering and pharmacologist of traditional Chinese medicine, who has unique research on blood stasis, said that modern medical research shows that notoginseng contains saponins, notoginseng element, notoginseng polysaccharide, amino acids and other effective ingredients, which have unique therapeutic and health care effects on blood system, cardiovascular and cerebrovascular system, central Shenjing system and other diseases, and are rare to maintain human health It's a precious medicine Wang Yaoxian, Dean of Dongzhimen Hospital of Beijing University of traditional Chinese medicine, also said: "Sanqi has the effects of inhibiting platelet aggregation, reducing blood viscosity, anticoagulation and preventing thrombosis It is called "blood vessel scavenger" and "aspirin in traditional Chinese medicine" Isadore Rothschild, M.D., a famous physician and health expert in the United States, was honored as "clinical professor of Rossi outstanding award" and served as a special member of the Heart Research Institute of the national health center of the United States In the special study of stroke and heart disease, it is believed that "the main causes of stroke and heart disease are the occlusion of blood vessels, cerebral hemorrhage and thrombus after arteriosclerosis." The main treatment for the disease with high mortality is anticoagulation and hemolytic thrombus In other words, the blood must be restored to the original "clear" appearance! He believes that "the development of new drugs for dissolving blood clots in blood vessels, like the role of dissolving blood clots in the heart and legs", is the future development direction of cardiovascular and cerebrovascular diseases The application of modern biotechnology from the traditional plant medicine Panax notoginseng saponin extract, to achieve his inference and desire Panax notoginseng extract is expected to become the second artemisinin as a traditional Chinese medicine After being extracted by Tu Youyou, it has become a model of innovative drug research and development in China It has attracted the attention of the international community and won the Nobel Prize Like Artemisia annua, Panax notoginseng has been widely recognized, but in the clinical application process, subject to the constraints of purification technology, the purity of effective substances is difficult to meet the standards of modern drugs Because of this, the application of modern biotechnology extraction of Panax notoginseng extract has made a breakthrough in the efficacy of development, known as "artemisinin in Panax notoginseng" However, due to the wide range of patients with cardiovascular and cerebrovascular diseases, according to the Chinese Journal of circulation, an authoritative academic journal of cardiovascular diseases, the prevalence of cardiovascular diseases in China is in a continuous rising stage, with one in five adults suffering from cardiovascular diseases Therefore, Panax notoginseng extract is essential for human health In recent years, Panax notoginseng, as a traditional Chinese medicine, has stepped into the international pharmaceutical market at a faster pace It has successively entered Japan, the United States and other international markets, and has been included in the French Pharmacopoeia Moreover, the establishment of international standards for Panax notoginseng medicinal materials and seeds and seedlings has also been approved by the international organization for Standardization (ISO), which has been officially released by Yunnan Provincial Department of science and technology It can be foreseen that the application of modern biological technology of Panax notoginseng extract will undoubtedly speed up Panax notoginseng as a mature clinical drug, recognized by the international market.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.